Contrast agents are chemical substances introduced to the anatomical or functional region being imaged, to increase the differences between different tissues or between normal and abnormal tissue, by altering the relaxation times. MRI contrast agents are classified by the different changes in relaxation times after their injection.
The design objectives for the next generation of MR contrast agents will likely focus on prolonging intravascular retention, improving tissue targeting, and accessing new contrast mechanisms. Macromolecular paramagnetic contrast agents are being tested worldwide. Preclinical data shows that these agents demonstrate great promise for improving the quality of MR angiography, and in quantificating capillary permeability and myocardial perfusion.
Ultrasmall superparamagnetic iron oxide (USPIO) particles have been evaluated in multicenter clinical trials for lymph node MR imaging and MR angiography, with the clinical impact under discussion. In addition, a wide variety of vector and carrier molecules, including antibodies, peptides, proteins, polysaccharides, liposomes, and cells have been developed to deliver magnetic labels to specific sites. Technical advances in MR imaging will further increase the efficacy and necessity of tissue-specific MRI contrast agents.

See also Adverse Reaction and Nephrogenic Systemic Fibrosis.

See also the related poll result: 'The development of contrast agents in MRI is'

Short name: Gd-DTPA-BMA, generic name: Gadodiamide, chemical compound: Gd-diethylenetriaminepentaacetate-bis(methylamide), central moiety: Gd
A paramagnetic MRI contrast agent (nonionic) with a small molecular weight linear chelate. Due to the linkage of two DTPA molecules through amide bonds the molecule is uncharged and has a low osmolality. The substance is excreted almost exclusively by the kidneys.

See also Nonionic Intravenous Contrast Agents and Omniscan®.

Short name: (Gd-DTPA)-17, 24 cascade polymer, generic name: Gadomer-17, 24, central moiety: Gd2+, relaxivity: r1=11.9, B0=1.0 T, r2=16.5, Dose: 0.05 mmol/kg
An intravascular macromolecular MRI contrast agent with positive enhancement under development (Bayer Schering Pharma AG) for MR angiography and tumor differentiation. The synthetic dendrimer with large molecular weight (17kD - limits agent to vascular space) is linked to Gadolinium. The renal excretion is slowed to intermediate molecular size. In MRA a longer lasting venous and arterial enhancement was seen with Gadomer-17 due to the particular pharmacokinetics of this agent.

See also Tumor Specific Agents, and Intravascular Contrast Agents.

(Hb) Haemoglobin is the major endogenous oxygen-binding molecule, responsible for binding oxygen in the lung and transporting it to the tissues by means of the circulation. Haemoglobin is contained in very high concentration in the red blood cells.
Haemoglobin is an Fe chelate tightly binding one Fe ion in its II oxidation state where it carries the charge 2+ (ferrous iron). If an oxygen molecule is bound to Hb, Hb is called oxyhaemoglobin, if no oxygen molecule is bound it is called deoxyhaemoglobin. When haemoglobin is oxidized (i.e. in a haematoma), Fe2+ is transformed into Fe3+. The resulting haemoglobin is then called metoxyhaemoglobin (Hb Fe3+).
Deoxyhaemoglobin and metoxyhaemoglobin act as paramagnetic contrast agents in MR, while oxyhaemoglobin is diamagnetic. This partly explains the special appearance of an aging haematoma in MR imaging and is also the basic of the blood oxygenation level dependent contrast (BOLD) used in functional magnetic resonance imaging of the brain (fMRI).

Reciprocals of the relaxation times, T1 and T2 (R1 = 1/T1 and R2 = 1/T2). There is often a linear relation between the concentration of MR contrast agents and the resulting change in relaxation rate. The rate of relaxation is influenced by molecules with protons that are tumbling. A slower tumble rate will result in faster relaxation rate (shorter relaxation time). Due to the molecular structure of fat with its larger size than water, fat will tumble slower than water molecules. The slower tumble rate of fat enables a faster relaxation rate.